Multifaceted role of tocotrienols in cardioprotection supports their structure: Function relation

Genes and Nutrition

Volumn 7, Issue 1, 2012, Pages 19-28

  Vasanthi, Hannah R ^a   Parameswari, R P ^b   Das, Dipak K ^c  

^a PONDICHERRY UNIVERSITY   (India)

^b SRI RAMACHANDRA UNIVERSITY   (India)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Antioxidant; Cardioprotection; Hypocholesterolemia; Ischemia; Preconditioning; Tocotrienol

Indexed keywords

ALPHA TOCOPHEROL DERIVATIVE; ALPHA TOCOTRIENOL; BETA TOCOTRIENOL; DELTA TOCOTRIENOL; GAMMA TOCOTRIENOL; MEVINOLIN; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CELL ADHESION; CONFERENCE PAPER; CORONARY ARTERY DISEASE; DIETARY INTAKE; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG MECHANISM; DRUG STRUCTURE; HEART PROTECTION; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; LIPID PEROXIDATION; LOW DRUG DOSE; MONOCYTE; NONHUMAN; STRUCTURE ACTIVITY RELATION; THROMBOSIS;

EID: 84860715458     PISSN: 15558932     EISSN: 18653499     Source Type: Journal    
DOI: 10.1007/s12263-011-0227-9     Document Type: Conference Paper

References (95)

1. Agarwal MK, Agarwal ML, Athar M, Gupta S (2004) Tocotrienol rich fraction of palm oil activates p53, modulates Bax/Bcl2 ratio and induces apoptosis independent of cell cycle association. Cell Cycle 3:205-211 (Pubitemid 40268698)
2. Ahn KS, Sethi G, Krishnan K, Aggarwal BB (2007) γ-tocotrienol inhibits nuclear factor-kB signaling pathway through inhibition of receptor-interacting protein and TAK1 leading to suppression of antiapoptotic gene products and potentiation of apoptosis. J Biol Chem 282:809-820 (Pubitemid 47076658)
3. Albers JJ, Brunzell JD, Knopp RH (1989) Apoprotein measurements and their clinical application in cholesterol screening. Clin Lab Med 34:4-8
4. Altman R (2004) Risk factor in coronary atherosclerosis athero-inflammation: the meeting point. Thromb J 1:4-8
5. Birringer M, Pfluger P, Kluth D et al (2002) Identities and differences in the metabolism of tocotrienols and tocopherols in HepG2 cells. J Nutr 132:3113-3118
6. Black TM, Wang P, Maed N et al (2000) Palm Tocotrienols Protect ApoE 1/2 mice from diet-induced atheroma formation. J Nutr 130:2420-2426
7. Brigelius-Flohe R, Traber MG (1999) Vitamin E: function and metabolism. FASEB J 13:1145-1155 (Pubitemid 29300361)
8. Burton GW, Ingold KU (1989) Vitamin E as in vitro and in vivo antioxidant. Ann N Y Acad Sci 570:7-22
9. Burton GW, Traber MG (1990) Vitamin E: antioxidant activity, biokinetics and bioavailability. Ann Rev Nut 10:357-382
10. Carlos TM, Harlan JM (1994) Leukocyte-Endothelial adhesion molecules. Blood 84:2068-2101 (Pubitemid 24296363)
11. Chao JT, Gapor A, Theriault A (2002) Inhibitory effect of deltatocotrienol, a HMG-CoA reductase inhibitor, mononocyteendothelial cell adhesion. J Nutr Sci Vitaminol 48:332-337 (Pubitemid 36205612)
12. Chen CW, Cheng HH (2006) A rice bran oil diet increases LDL receptor and HMG-CoA reductase mRNA expressions and insulin sensitivity in rats with streptozotocin/nicotinamide induced type 2 diabetes. J Nutr 136:1472-1476
13. Correll CC, Ng L, Edwards PA (1994) Identification of farnesol as the non-sterol derivative of mevalonic acid required for the accelerated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Biol Chem 269:17390-17393
14. Crowell PL, Chang RR, Ren ZB et al (1991) Selective inhibition of isoprenylation of 21-26-kDa proteins by the anticarcinogen d-limonene and its metabolites. J Biol Chem 266:17679-17685 (Pubitemid 21907991)
15. Das S, Powell SR, Wang P, Divald A, Nesaretnam K, Tosaki A, Cordis GA, Maulik N, Das DK (2005) Cardioprotection with palm tocotrienol: antioxidant activity of tocotrienol is linked with its ability to stabilize proteasomes. Am J Physiol Heart Circ Physiol 289:361-367
16. Das M, Das S, Wang P, Powell SR, Das DK (2008a) Caveolin and proteasome in tocotrienol mediated myocardial protection. Cell Physiol Biochem 22:287-294
17. Das S, Lekli I, Das M, Das DK (2008b) Cardioprotection with palm oil tocotrienols: comparision of different isomers. Am J Physiol Heart Circ Physiol 294:970-978
18. Douglas CE, Chan AC, Choy PC (1986) Vitamin E inhibits platelet phospholipase A2. Biochem Biophys Acta 876:639-645
19. Eitsuka T, Nakagawa K, Miyazawa T (2006) Down-regulation of telomerase activity in DLD-1 human colorectal adenocarcinoma cells by tocotrienol. Biochem Biophys Res Commun 348:170-175 (Pubitemid 44163497)
20. Elson CE, Yu SG (1994) The chemoprevention of cancer by mevalonate-derived constituents of fruits and vegetables. J Nutr 124:607-614 (Pubitemid 24157279)
21. Esterhuyse AJ, Toit ED, Rooyen JV (2005) Dietary red palm oil supplementation protects against the consequences of global ischemia in the isolated perfused rat heart. Asia Pac J Clin Nutr 14:340-347 (Pubitemid 43219090)
22. Fairus S, Nor RM, Cheng HM, Sundram K (2006) Postprandial metabolic fate of tocotrienol-rich vitamin E differs significantly from that of α- tocopherol. Am J Clin Nutr 84:835-842 (Pubitemid 44715666)
23. Goldstein JL, Brown MS (1990) Regulation of the mevalonate pathway. Nature 343:425-430
24. Hirsh J (1987) Hyperactive platelets and complications of coronary artery disease. N Engl J Med 316:1543-1544 (Pubitemid 17076241)
25. Hosomi A, Arita M, Sato Y et al (1997) Affinity for α-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Lett 409:105-108 (Pubitemid 27248576)
26. Hunter SC, Cahoon EB (2007) Enhancing Vitamin E in oilseeds: unraveling tocopherol and tocotrienol biosynthesis. Lipids 42:97-108 (Pubitemid 351912047)
27. Ikeda S, Tohyama T, Yoshimura H et al. (2003) Dietary alphatocopherol decreases alpha-tocotrienol but not gamma-tocotrienol concentration in rats. J Nutr 133:428-434 (Pubitemid 36172895)
28. Inokuchi H, Hirokane H, Tsuzuki T et al (2003) Antiangiogenic activity of tocotrienol. Biosci Biotechnol Biochem 67:1623-1627
29. Iqbal J, Minhajuddin M, Beg ZH (2003) Suppression of 7, 12-dimethylbenz[α]anthraceneinduced carcinogenesis and hypercholesterolaemia in rats by Tocotrienol rich fraction isolated from rice bran oil. Eur J Cancer Prev 12:447-453
30. Kamal-Eldin A, Appelqvist LA (1996) The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids 31:671-701 (Pubitemid 26240763)
31. Kamat J, Devasagayam TPA (1995) Tocotrienols from palm oil as potent inhibitors of lipid peroxidation and protein oxidation in rat brain mitochondria. Neurosci Lett 195:179-182
32. Kasparek S. (1980). Chemistry of tocopherols and tocotrienols. In Vitamin E: a Comprehensive Treatise-Machlin L. J.Ed Mml Dekker, Inc, New York
33. Khanna S, Roy S, Ryu H et al (2003) Molecular basis of vitamin E action: tocotrienols modulates 12-lipoxygenase, a key mediator of glutamate induced neurodegeneration. J Biol Chem 278:43508-43515 (Pubitemid 37345974)
34. Kobayashi H, Kanno C, Yamauchi K, Tsugo T (1975) Identification of alpha-, beta gamma-, and delta-tocopherols and their contents in human milk. Biochim Biophys Acta 380:282-290
35. Lam A, Lopaschuk GD (2007) Anti-anginal effects of partial fatty acid oxidation inhibitors. Curr Opin Pharmacol 7:179-185 (Pubitemid 46404745)
36. Lekli I, Ray D, Mukherjee S, Gurusamy N et al (2009) Coordinated autophagy with resveratrol and gamma-tocotrienol confers synergetic cardioprotection. J Cell Mol Med 14:2506-2518
37. Li F, Tan W, Kang Z et al (2010) Tocotrienol enriched palm oil prevents atherosclerosis through modulating the activities of peroxisome proliferators-activated receptors. Atherosclerosis 211:278-282
38. Libby P (2002) Inflammation in atherosclerosis. Nature 420:868-874 (Pubitemid 36019640)
39. McIntyre B, Briski KP, Gapor A, Sylvester PW (2000) Antiproliferative and apoptotic effects tocopherols and Tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells. Proc Soc Exp Biol Med 224:292-301 (Pubitemid 30643508)
40. Miyazawa T, Inokuchi H, Hirokane H et al (2004) Antiangiogenic potential of tocotrienol in vitro. Biochemistry (Mosc) 69:67-69
41. Mutalib MSA, Khaza'ai H, Wahle KWJ (2003) Palm-tocotrienol rich fraction (TRF) is a more effective inhibitor of LDL oxidation and endothelial cell lipid peroxidation than alphatocopherol in vitro. Food Res Int 36:405-413 (Pubitemid 36499844)
42. Nafeeza MI, Norzana AG, Jalaluddin HL, Gapor MT (2001) The effects of a tocotrienol-rich fraction on experimentally induced atherosclerosis in the aorta of rabbits. Malays J Pathol 23:17-25
43. Naito Y, Shimozawa M, Kuroda M et al (2005) Tocotrienols reduce 25 hydroxycholesterol-induced monocyte endothelial cell interactions by inhibiting the surface expression of adhesion molecules. Atherosclerosis 180:19-25
44. Napolitano M, Avanzi L, Manfredini S, Bravo E (2007) Effects of new combinative antioxidant FeAOX-6 and a-tocotrienol on macrophage atherogenesis related functions. Vascular Pharmacol 46:394-405 (Pubitemid 46552283)
45. Nesaretnam K, Devasagayam TPA, Singh BB, Basiron Y (1993) Influence of palm oil or its tocotrienol-rich fraction on lipid peroxidation potential on rat liver mitochondria and microsomes. Biochem Mol Biol Int 30:159-167 (Pubitemid 23199787)
46. Niki E, Kawakami A, Satio M et al (1985) Effect of phytyl side chain of vitamin E on its antioxidant activity. J Biol Chem 260:2191-2196 (Pubitemid 15105714)
47. Noguchi N, Hanyu R, Nonaka A et al (2003) Inhibition of THP-1 cell adhesion to endothelial cells by alpha-tocopherol and alphatocotrienol is dependent on intracellular concentration of the antioxidants. Free Radic Biol Med 34:1614-1620 (Pubitemid 36638721)
48. Packer L, Weber SU, Rimbach G (2001) Molecular aspects of a-tocotrienol antioxidant action and cell signalling. J Nutr 131:369-373
49. Parker RA, Pearce BC, Clark RW et al (1993) Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-Hydroxy-3-methylglutaryl-coenzyme A reductase. J Biol Chem 268:11230-11238 (Pubitemid 23162316)
50. Pearce BC, Parker RA, Deason ME (1992a) Inhibitors of cholesterol biosynthesis. Hypocholesterolemic and antioxidant activities of benzopyran and tetrahydroaphthalene analogues of the tocotrienols. J Med Chem 37:526-541 (Pubitemid 24094834)
51. Pearce BC, Parker RA, Deason ME et al (1992b) Hypocholesterolemic activity of synthetic and natural tocotrienols. J Med Chem 35:3595-3606
52. Pearce BC, Parker RA, Deason ME et al (1994) Inhibitors of cholesterol biosynthesis-Hypocholesterolemic and antioxidant activities of Benzopyran and Tetrahydronaphthalene Analogues of the Tocotrienols. J Med Chem 37:526-541 (Pubitemid 24094834)
53. Pederson TR (1999) Statin trials, goals of cholesterol-lowering therapy after AMI. Am Heart J 138:177-182
54. Qureshi AA, Peterson DM (2001) The combined effects of novel tocotrienols and lovastatin on lipid metabolism in chickens. Atherosclerosis 156:39-47 (Pubitemid 32429593)
55. Qureshi AA, Burger WC, Peterson DM, Elson CE (1986) The structure of an inhibitor of cholesterol biosynthesis isolated from barley. J Biol Chem 261:10544-10550 (Pubitemid 17194832)
56. Qureshi AA, Qureshi N, Halser-Rapacz JO et al (1991a) Dietary tocotrienols reduce concentrations of plasma cholesterol, apolipoprotein B, thromboxane B2, and platelet factor 4 in pigs with inherited hyperlipidemias. Am J Clin Nutr 53:1042-1046
57. Qureshi AA, Qureshi N, Wright JfK et al (1991b) Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (palmvitee). Am J Clin Nutr 102:1-6
58. Qureshi N, Hofman J, Qureshi AA (1993) Inhibition of LPS induced tumor necrosis factor synthesis and hypocholesterolermic effect of novel tocotrienols. In ''Proceedings of the PORIM International Palm Oil Congress''. September 20-25, N16
59. Qureshi AA, Bradlow BA, Brace L (1995) Response of hypercholesterolemic subjects to administration of tocotrienols. Lipids 30:1171-1177
60. Qureshi AA, Pearce C, Nor RM et al (1996) Dietary d-tocopherol attenuates the impact of d-tocotrienol on hepatic 3-hydroxy-3- methylglutaryl coenzyme A reductase activity in chickens. J Nutr 126:389-394 (Pubitemid 26060531)
61. Qureshi AA, Bradlow BA, Salser WA, Brace LD (1997) Novel tocotrienols of rice bran modulate cardiovascular disease risk parameters of hypercholesterolemic humans. Nutr Biochem 8:290-298 (Pubitemid 27305619)
62. Qureshi AA, Peterson DM, Hasler Rapacz JO, Rapacz J (2001a) Novel Tocotrienols of rice bran suppress cholesterogenesis in hereditary hypercholesterolemic swine. J Nutr 131:223-230 (Pubitemid 32115360)
63. Qureshi AA, Sami SA, Salser WA et al (2001b) Synergistic effect of tocotrienol-rich fraction (TRF (25)) of rice bran and lovastatin on lipid parameters in hypercholesterolemic humans. J Nutr Biochem 12:318-329 (Pubitemid 32552047)
64. Qureshi AA, Sami SA, Salser WA, Khan FA (2002) Dose-dependent suppression of serum cholesterol by tocotrienol-rich fraction (TRF25) of rice bran in hypercholesterolemic humans. Atherosclerosis 161:199-207 (Pubitemid 34214837)
65. Rifkind BM (1998) Clinical trials of reducing low-density lipoprotein concentrations. Endocrinol Metab Clin North Am 27:585-595 (Pubitemid 28446949)
66. Ross R (1999) Atherosclerosis-an inflammatory disease. New Engl J Med 340:115-126
67. Scanu AM, Fless GM (1990) Lipoprotein (a): heterogeneity and biological relevance. J Clin Invest 86:1709-1715
68. Sen CK, Khanna S, Roy S, Packer LJ (2000) Molecular basis of Vitamin E action. J Biol Chem 275:13049-13055
69. Sen CK, Khanna S, Roy S (2006) Tocotrienols: vitamin E beyond tocopherols. Life Sci 78:2088-2098
70. Serbinova EA, Packer L (1994) Antioxidant properties of alphatocopherol and alpha -tocotrienol. Methods Enzymol 234:354-366
71. Serbinova E, Khwaja S, Catudioc J et al (1992) Palm oil vitamin E protects against ischemia/reperfusion injury in the isolated perfused Langendorff heart. Nutr Res 12:203-215
72. Serbinova EA, Tsuchiya M, Goth S, Kagan VE, Packer L (1993) Antioxidant action of a-tocopherol and a-tocotrienol in membranes. In: Vitamin E in health and disease. Eds. L. Inc., New York, 235-243
73. Sever N, Song BL, Yabe D et al (2003) Insig-dependent ubiquitination and degradation of mammalian 3-hydroxy-3-methylglutaryl- CoA reductase stimulated by sterols and geranylgeraniol. J Biol Chem 278:52479-52490 (Pubitemid 38035841)
74. Shah S, Sylvester PW (2004) Tocotrienol-induced caspase-8 activation is unrelated to death receptor apoptotic signaling in neoplastic mammary epithelial cells. Exp Biol Med (Maywood) 229:745-755 (Pubitemid 39166478)
75. Shukla S, Gupta S (2005) Dietary agents in the chemoprevention of prostate Cancer. Nutr Cancer 53:18-32 (Pubitemid 43068550)
76. Sniderman A, Shapiro S, Marpole D, Skinner B, Teng B, Kwiterovich PO (1980) Association of coronary atherosclerosis with hyperbetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low-density (beta) lipoproteins]. Proc Natl Acad Sci USA 77:604-608 (Pubitemid 10141071)
77. Song BL, Debose-Boyd RA (2006) Insig-dependent ubiquitination and degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase stimulated by δ- and γ-tocotrienols. J Biol Chem 281:25054-25061
78. Sporn MB, Suh N (2002) Chemoprevention: an essential approach to controlling cancer. Nat Rev Cancer 2:537-543 (Pubitemid 37328935)
79. Stanley WC, Recchia FA, Lopaschuk GD (2005) Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 85:1093-1129 (Pubitemid 40894649)
80. Steinberg D, Parthasarathy S, Carew TE et al (1989) Beyond cholesterol: modification of lowdensity lipoprotein that increases its atherogenicity. N Engl J Med 320:915-924 (Pubitemid 19101597)
81. Sundram K, Gapor A (1992) Vitamin E from palm oil: its extraction and nutritional properties. Lipid Technol 4:137-141
82. Suzuki YJ, Tsuchiya M, Wassall SR (1993) Structural and dynamic membrane properties of a-tocopherol and a-tocotrienol: implications to the molecular mechanism of their antioxidant potency. Biochemistry 32:10692-10699 (Pubitemid 23327802)
83. Tan B (2010) Tocotrienols: the New Vitamin E. Spacedocnet, www.spacedoc.net
84. Theriault A, Wang Q, Gapor A, Adeli K (1999) Effects of γ-tocotrienol on ApoB Synthesis, degradation, and secretion in HepG2 Cells. Arterioscler Thromb Vasc Biol 19:704-712 (Pubitemid 29135175)
85. Theriault A, Chao JT, Gapor A (2002) Tocotrienol is the most effective vitamin E for reducing endothelial expression of adhesion molecules and adhesion to monocytes. Atherosclerosis 160:21-30 (Pubitemid 34076642)
86. Tomeo AC, Geller M, Watkins TR, Gapor A, Bierenbaum ML (1995) Antioxidant effects of tocotrienols in patients with hyperlipidemia and carotid stenosis. Lipids 30:1179-1183
87. Tziakas DN, Chalikias GK, Kaski JC et al (2006) Inflammatory and anti-inflammatory variable clusters and risk prediction in acute coronary syndrome patients: a factor analysis approach. Atherosclerosis 193:196-203
88. Ussher JR, Lopaschuk GD (2009) Targeting malonyl CoA inhibition of mitochondrial fatty acid uptake as an approach to treat cardiac ischemia/reperfusion. Basic Res Cardiol 104:203-210
89. Wada S, Satomi Y, Murakoshi M et al (2005) Tumor suppressive effects of tocotrienol in vivo and in vitro. Cancer Lett 229:181-191 (Pubitemid 41429357)
90. Wang X, Quinn PJ (1999) Vitamin E and its function in membranes. Prog Lipid Res 38:309-336 (Pubitemid 29408248)
91. Watkins L, Lenz P, Gapor A, Struck M, Tomeo A, Bierenbaum M (1993) γ-tocotrienol as a hypocholesterolemic and antioxidant agent in rats fed atherogenic diets. Lipids 28:1113-1118
92. Wu SJ, Liu PL, Lean-Teik N (2008) γ - Tocotrienol-rich fraction of palm oil exhibits anti-inflammatory property by suppressing the expression of inflammatory mediators in human monocytic cells. Mol Nutr Food Res 52:921-929
93. Yam ML, Abdul Hafid SR, Cheng HM, Nesaretnam K (2009) Tocotrienols suppress proinflammatory markers and cyclooxygenase- 2 expression in RAW264.7 macrophages. Lipids 44:787-797
94. Yap SP, Yuen KH, Lim AB (2003) Influence of route of administration on the absorption and disposition of α-, γ-, and δ- tocotrienols in rats. J Pharm Pharmacol 55:53-58 (Pubitemid 36142081)
95. Yu F-L, Gapor A, Bender W (2005) Evidence for the preventive effect of the polyunsaturated phytol side chain in tocotrienols on 17 β-estradiol epoxidation. Cancer Detect Prev 29:383-388 (Pubitemid 41267298)